Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Endo Health Solutions Inc    ENDP

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Senate Panel Seeks Info From J&J, Endo, Others Over Concern On Painkiller Marketing -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/09/2012 | 08:44pm CEST

The Senate Finance Committee is looking into possible links between three drug companies and nonprofit medical groups, citing concerns about the groups' advocacy of painkillers, Reuters reported Wednesday.

The panel sent letters to Johnson & Johnson (JNJ), Endo Pharmaceuticals Holdings Inc. (>> Endo Pharmaceuticals Holdings Inc) and Purdue Pharma LP and seven medical groups seeking documents about their financial connections, Reuters reported.

Sen. Max Baucus (D., Mont.), the committee's chairman, said in a statement that "painkillers have an important role in health care when prescribed and used properly, but pushing misinformation on consumers to boost profits is not only wrong, it's dangerous," Reuters reported.

Reuters said officials at the three drug companies weren't immediately available for comment.

Full story at http://www.reuters.com/article/2012/05/09/us-usa-painkillers-investigation-idUSBRE84811420120509

-Dow Jones Newswires; 212-416-2900

Stocks mentioned in the article : Endo Pharmaceuticals Holdings Inc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on ENDO HEALTH SOLUTIONS INC
03/31 U.S. FTC sues Endo alleging antitrust violations
03/31DJFTC Accuses Endo of Paying Off Generic Drugmakers
03/18DJValeant Fears Infect Specialty Sector
03/15 TIMELINE : More trouble for Valeant as possible debt default looms
02/29 S&P 500 slides below closely watched threshold
02/04DJBoston Scientific Narrows Loss as Sales Rise
01/04DJFDA Tightens Rules for Mesh Device Used in Some Pelvic Surgeries
2015DJValeant Share Price Surges on Citigroup Recommendation
2015 Perrigo shareholders snub drugmaker Mylan's $26 billion hostile bid
2015DJMylan Loses Hostile Bid for Perrigo--2nd Update
Advertisement
Income Statement Evolution
More Financials